The Netherlands Cancer Institute

6 results found.

Small Cell Lung Cancer, or Lung Cancer Clinical Trial using Radiation Prophylactic Cranial Irradiation; Radiation Hippocampal Avoidance PCI

The Netherlands Cancer Institute - Recruiting 18 years or older.
- Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance in SCLC a Randomized Phase III Trial.
Radiation Prophylactic Cranial Irradiation; Radiation Hippocampal Avoidance PCI

Colorectal Cancer Clinical Trial using Dacomitinib; PD-0325901; Irinotecan; Docetaxel; Capecitabine

The Netherlands Cancer Institute - Recruiting 18 years or older.
- Phase I/II Study With the Combination of Dacomitinib and PD-0325901 in Advanced KRAS Mutation Positive Colorectal, Non-small Cell Lung and Pancreatic Cancer.
Dacomitinib; PD-0325901; Irinotecan; Docetaxel; Capecitabine

Breast Cancer, or HER2 Positive Clinical Trial using PTC+Pertuzumab; FEC-T+Pertuzumab

The Netherlands Cancer Institute - Recruiting 18 years or older.
- Optimizing Neoadjuvant Systemic Treatment for HER2 Positive Breast Cancer - the TRAIN-2 Study.
PTC+Pertuzumab; FEC-T+Pertuzumab

NSCLC Clinical Trial using Radiotherapy

The Netherlands Cancer Institute - Recruiting 18 years or older.
- Dose Escalation by Boosting Radiation Dose Within the Primary Tumor on the Basis of a Pre-treatment FDG-PET-CT Scan in Stage IB, II and III NSCLC: a Randomized Phase II Trial.
Radiotherapy

Neoplasms Clinical Trial using Capecitabine, 5-fluorouracil

The Netherlands Cancer Institute - Recruiting 18 years or older.
- Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines.
Capecitabine, 5-fluorouracil

NSCLC Clinical Trial using Olaparib; Cisplatin; Radiation

The Netherlands Cancer Institute - Recruiting 18 years or older.
- Olaparib Dose Escalating Trial in Patients Treated With Radiotherapy With or Without Daily Dose Cisplatin for Locally Advanced Non-small Cell Lung Carcinoma.
Olaparib; Cisplatin; Radiation